{"id":28827,"date":"2023-01-10T07:59:48","date_gmt":"2023-01-10T06:59:48","guid":{"rendered":"https:\/\/master-3.corporate.ferring.tech\/?p=28827"},"modified":"2023-01-10T07:59:48","modified_gmt":"2023-01-10T06:59:48","slug":"ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer","status":"publish","type":"post","link":"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/","title":{"rendered":"Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer"},"content":{"rendered":"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h2 style=\"color: #0088ce\">Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer<\/h2>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<ul>\n<li><em>Pierre-Yves Berclaz joins Ferring\u2019s Executive Committee as Executive Vice President, Chief Medical Officer<\/em><\/li>\n<li><em>Pierre-Yves previously held the position of Senior Vice President, Head of Global Medical Affairs for Neurology and Immunology at Merck KGaA\/EMD Serono<\/em><\/li>\n<\/ul>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<p><strong>Saint-Prex, Switzerland \u2013 10 January 2023 \u2013 <\/strong>Ferring Pharmaceuticals announced today that Pierre-Yves Berclaz has joined the company as its new Executive Vice President, Chief Medical Officer.<\/p>\n<p>Pierre-Yves brings extensive medical and scientific expertise to Ferring, having previously held the position of Senior Vice President, Head of Global Medical Affairs for Neurology and Immunology at Merck KGaA\/EMD Serono, based in Boston, USA.<\/p>\n<p>Prior to this, Pierre-Yves spent over 14 years at Eli Lilly, holding leadership roles in Medical Affairs, Global Clinical Development, Clinical Pharmacology and Discovery Research in multiple therapeutic areas, including immunology, neuroscience, diabetology and oncology. Pierre-Yves also spent seven years as Chief Medical Officer for Eli Lilly Japan, where he led the clinical and medical efforts in the successful launches of numerous new molecular entities (NMEs) and line extensions.<\/p>\n<p>Per Falk, President of Ferring, commented, <em>\u201cI am delighted to welcome Pierre-Yves Berclaz to the Ferring family. Pierre-Yves will ensure that the needs of our patients is the foundation on how we conduct our business and continue to deliver on our purpose to help people around the world to build families and live better lives.\u201d<\/em><\/p>\n<p>Earning a medical degree from the University of Lausanne, Pierre-Yves achieved his specialty training in Paediatrics at the Universities of Lausanne and Geneva. He obtained his sub-specialty in Pulmonary Medicine and his PhD in Molecular Biology from the Cincinnati College of Medicine, where he served as Assistant Professor, Paediatric Pulmonology prior to joining Eli Lilly.<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3>About Ferring Pharmaceuticals<\/h3>\n<p>Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs around 6,000 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.<\/p>\n<p>Learn more at <a href=\"http:\/\/www.ferring.com\/\">www.ferring.com<\/a>, or connect with us on <a href=\"https:\/\/twitter.com\/ferring\">Twitter<\/a>, <a href=\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\">Facebook<\/a>, <a href=\"https:\/\/www.instagram.com\/ferringpharmaceuticals\/\">Instagram<\/a>, <a href=\"https:\/\/www.linkedin.com\/company\/ferring-pharmaceuticals\/\">LinkedIn<\/a> and <a href=\"https:\/\/www.youtube.com\/channel\/UC6Ss0Uwv54xTGmM_EDEzQPA\">YouTube<\/a>.<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 style=\"color: #0088ce\">For more information, please contact<\/h3>\n<p><strong>Carine Julen<br \/>\n<\/strong><em>Corporate Communications Manager<br \/>\n<\/em>+41 76 301 0178 (mobile)<br \/>\n+41 79 191 0632<br \/>\n<a href=\"mailto:carine.julen@ferring.com\">carine.julen@ferring.com<\/a><\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_row element_name=”Row” wrap_type=”content-width” parallax_image_height=”content-height” parallax_image_movement=”fixed” parallax_image_speed=”0.5″ bg_video_loop=”yes” parallax_video_height=”window-height” parallax_video_overlay=”none” row_overlay_opacity=”0″ row_col_pos=”default” minimize_row=”no” width=”1\/1″ el_position=”first last”] [spb_button button_text=”READ MORE PRESS RELEASES” button_size=”standard” button_colour=”accent” button_type=”standard” rounded=”no” button_dropshadow=”no” button_link=”\/media\/press-releases\/” button_target=”_self” align=”center” animation=”none” animation_delay=”0″ width=”1\/1″ el_position=”first last”] [\/spb_row]\n","protected":false},"excerpt":{"rendered":"<p>[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Pierre-Yves Berclaz joins Ferring\u2019s Executive Committee as Executive Vice President, Chief Medical Officer Pierre-Yves previously held the position of Senior Vice President, Head of Global Medical […]<\/p>\n","protected":false},"author":4746,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1478],"tags":[],"class_list":["post-28827","post","type-post","status-publish","format-standard","hentry","category-press-release-2023"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.3 (Yoast SEO v23.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer - Ferring Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer\" \/>\n<meta property=\"og:description\" content=\"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Pierre-Yves Berclaz joins Ferring\u2019s Executive Committee as Executive Vice President, Chief Medical Officer Pierre-Yves previously held the position of Senior Vice President, Head of Global Medical […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Ferring Global\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-10T06:59:48+00:00\" \/>\n<meta name=\"author\" content=\"celia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ferring\" \/>\n<meta name=\"twitter:site\" content=\"@ferring\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"celia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/\"},\"author\":{\"name\":\"celia\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/3f52e318dbb73150503a8699dc63d3d0\"},\"headline\":\"Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer\",\"datePublished\":\"2023-01-10T06:59:48+00:00\",\"dateModified\":\"2023-01-10T06:59:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/\"},\"wordCount\":694,\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"articleSection\":[\"PRESS RELEASE 2023\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/\",\"url\":\"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/\",\"name\":\"Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer - Ferring Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/#website\"},\"datePublished\":\"2023-01-10T06:59:48+00:00\",\"dateModified\":\"2023-01-10T06:59:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ferring.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ferring.com\/#website\",\"url\":\"https:\/\/www.ferring.com\/\",\"name\":\"Ferring Pharmaceuticals\",\"description\":\"Helping people live better lives\",\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ferring.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ferring.com\/#organization\",\"name\":\"Ferring\",\"url\":\"https:\/\/www.ferring.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"contentUrl\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"width\":236,\"height\":154,\"caption\":\"Ferring\"},\"image\":{\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\",\"https:\/\/x.com\/ferring\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/3f52e318dbb73150503a8699dc63d3d0\",\"name\":\"celia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/870a6ac667163f11e001926e332b8eb0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/870a6ac667163f11e001926e332b8eb0?s=96&d=mm&r=g\",\"caption\":\"celia\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer - Ferring Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/","og_locale":"en_US","og_type":"article","og_title":"Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer","og_description":"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Pierre-Yves Berclaz joins Ferring\u2019s Executive Committee as Executive Vice President, Chief Medical Officer Pierre-Yves previously held the position of Senior Vice President, Head of Global Medical […]","og_url":"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/","og_site_name":"Ferring Global","article_publisher":"https:\/\/www.facebook.com\/ferringpharmaceuticals\/","article_published_time":"2023-01-10T06:59:48+00:00","author":"celia","twitter_card":"summary_large_image","twitter_creator":"@ferring","twitter_site":"@ferring","twitter_misc":{"Written by":"celia","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/#article","isPartOf":{"@id":"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/"},"author":{"name":"celia","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/3f52e318dbb73150503a8699dc63d3d0"},"headline":"Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer","datePublished":"2023-01-10T06:59:48+00:00","dateModified":"2023-01-10T06:59:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/"},"wordCount":694,"publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"articleSection":["PRESS RELEASE 2023"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/","url":"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/","name":"Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer - Ferring Global","isPartOf":{"@id":"https:\/\/www.ferring.com\/#website"},"datePublished":"2023-01-10T06:59:48+00:00","dateModified":"2023-01-10T06:59:48+00:00","breadcrumb":{"@id":"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ferring.com\/ferring-pharmaceuticals-appoints-pierre-yves-berclaz-as-executive-vice-president-chief-medical-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ferring.com\/"},{"@type":"ListItem","position":2,"name":"Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.ferring.com\/#website","url":"https:\/\/www.ferring.com\/","name":"Ferring Pharmaceuticals","description":"Helping people live better lives","publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ferring.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ferring.com\/#organization","name":"Ferring","url":"https:\/\/www.ferring.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/","url":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","contentUrl":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","width":236,"height":154,"caption":"Ferring"},"image":{"@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ferringpharmaceuticals\/","https:\/\/x.com\/ferring"]},{"@type":"Person","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/3f52e318dbb73150503a8699dc63d3d0","name":"celia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/870a6ac667163f11e001926e332b8eb0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/870a6ac667163f11e001926e332b8eb0?s=96&d=mm&r=g","caption":"celia"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/28827"}],"collection":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/users\/4746"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/comments?post=28827"}],"version-history":[{"count":1,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/28827\/revisions"}],"predecessor-version":[{"id":28828,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/28827\/revisions\/28828"}],"wp:attachment":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/media?parent=28827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/categories?post=28827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/tags?post=28827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}